Venture
SOPTrace GxP
SOPTrace GxP turns document review into controlled, evidence-linked SOP-driven workflows for regulated environments.
The regulatory document challenge
Pharmaceutical, biotech, and medical device companies operate under strict regulatory requirements that demand rigorous document control for standard operating procedures, batch records, validation protocols, and quality documentation. Review cycles are slow, labor-intensive, and prone to human error. A single document can pass through dozens of hands and still contain inconsistencies that trigger regulatory findings.
The core problem is that document review in regulated environments relies on manual processes that are difficult to scale and audit. Reviewers must check for compliance with multiple regulations, internal policies, and previous revisions while maintaining a complete audit trail. SOPTrace GxP addresses this by turning document review into controlled, SOP-driven workflows powered by the Multi-Resolution Process Virtual Machine.
What SOPTrace GxP does
SOPTrace GxP uses MRP-VM to encode review processes as structured, executable workflows. Each SOP becomes a controlled process with defined steps, approval gates, evidence requirements, and escalation paths. Reviewers follow the workflow, which ensures that every required check is performed, every approval is recorded, and every decision is linked to its supporting evidence.
The platform does not replace human judgment. It structures the process so that reviewers can focus on substantive decisions while the system handles process compliance, evidence capture, and audit trail generation. This reduces review cycle time while improving completeness and consistency.
Evidence-linked audit readiness
Every action in SOPTrace GxP is recorded with cryptographic integrity. When a reviewer approves a document, the system captures who approved it, when, what version of the document was approved, what evidence supported the decision, and what policies were checked. This creates a complete, tamper-evident audit trail that is ready for regulatory inspection at any time.
For quality teams preparing for audits, this means the evidence is already organized and linked to the decisions it supports. Instead of spending weeks assembling audit responses, teams can present the regulator with a complete trace from document creation through review, approval, and implementation. This reduces audit stress and improves regulatory outcomes.
Target customers and use cases
The primary customers are pharmaceutical quality assurance teams that manage hundreds or thousands of SOPs across multiple sites and regulatory jurisdictions. Biotech companies need the same capabilities but often with smaller teams and faster development cycles. Medical device manufacturers face similar requirements under ISO 13485 and FDA 21 CFR Part 820.
Clinical research organizations managing trial documentation, contract manufacturing organizations handling client SOPs, and any regulated organization that needs to demonstrate document control compliance are all potential customers. The platform scales from small teams to enterprise deployments across global operations.
Value proposition and ROI
The measurable value comes from reduced review cycle time, improved consistency across reviews, and lower audit preparation costs. Organizations that adopt SOPTrace GxP typically see review cycles shortened by 40-60% because structured workflows eliminate back-and-forth and ensure reviewers have the right information at each step.
Beyond cycle time, the platform reduces the risk of regulatory findings related to document control. When every decision is linked to evidence and every process step is recorded, regulators can see immediately that the organization has control over its documentation. This translates to fewer observations, faster audit closeouts, and reduced compliance cost over time.
Venture path and market entry
SOPTrace GxP enters the market as a SaaS platform targeting pharmaceutical quality teams as the initial beachhead. The platform integrates with existing document management systems and electronic quality management systems rather than requiring replacement. This reduces switching costs and accelerates adoption.
The venture follows a subscription model with pricing based on document volume and user count. Professional services for workflow design, validation support, and regulatory guidance provide additional revenue. As the platform gains traction in pharma, it expands into adjacent regulated industries including medical devices, clinical research, and food and beverage manufacturing.
Request
Request SOPTrace Dossier
Dossier covers the MRP-VM regulatory workflow engine, target document families, pharma and med-device go-to-market strategy, and regulatory validation path. Shared under NDA with qualified investors and regulated-industry operators.